Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational Methods Used in Hit-to-Lead and Lead Optimization Stages of Structure-Based Drug Discovery
Alexander Heifetz, Michelle Southey, Iñaki Morao, et al.
Methods in molecular biology (2017), pp. 375-394
Closed Access | Times Cited: 21

Showing 21 citing articles:

DeepBindRG: a deep learning based method for estimating effective protein–ligand affinity
Haiping Zhang, Linbu Liao, Konda Mani Saravanan, et al.
PeerJ (2019) Vol. 7, pp. e7362-e7362
Open Access | Times Cited: 98
In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy
Charles Gnanaraj, Mahendran Sekar, Shivkanya Fuloria, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2834-2834
Open Access | Times Cited: 50
A practical guide to machine-learning scoring for structure-based virtual screening
Viet‐Khoa Tran‐Nguyen, Muhammad Junaid, Saw Simeon, et al.
Nature Protocols (2023) Vol. 18, Iss. 11, pp. 3460-3511
Closed Access | Times Cited: 38
Beyond the Flavour: The Potential Druggability of Chemosensory G Protein-Coupled Receptors
Antonella Di Pizio, Maik Behrens, Dietmar Krautwurst
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1402-1402
Open Access | Times Cited: 63
Challenges in natural product-based drug discovery assisted within silico-based methods
Conrad V. Simoben, Smith B. Babiaka, Aurélien F. A. Moumbock, et al.
RSC Advances (2023) Vol. 13, Iss. 45, pp. 31578-31594
Open Access | Times Cited: 16
Intermolecular interaction among Remdesivir, RNA and RNA-dependent RNA polymerase of SARS-CoV-2 analyzed by fragment molecular orbital calculation
Koichiro Kato, Teruki Honma, Kaori Fukuzawa
Journal of Molecular Graphics and Modelling (2020) Vol. 100, pp. 107695-107695
Open Access | Times Cited: 29
FEPrepare: A Web-Based Tool for Automating the Setup of Relative Binding Free Energy Calculations
Stamatia Zavitsanou, Alexandros Tsengenes, Michail Papadourakis, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4131-4138
Closed Access | Times Cited: 24
Assessing multiple score functions in Rosetta for drug discovery
Shannon T. Smith, Jens Meiler
PLoS ONE (2020) Vol. 15, Iss. 10, pp. e0240450-e0240450
Open Access | Times Cited: 26
EmbedDTI: Enhancing the Molecular Representations via Sequence Embedding and Graph Convolutional Network for the Prediction of Drug-Target Interaction
Jin Yuan, Jiarui Lu, Runhan Shi, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1783-1783
Open Access | Times Cited: 22
Multitargeted pharmacokinetics, molecular docking and network pharmacology-based identification of effective phytocompounds from Sauropus androgynus (L.) Merr for inflammation and cancer treatment
Ekambaram Gayathiri, Palanisamy Prakash, Maqusood Ahamed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7883-7896
Closed Access | Times Cited: 8
Conformational Searching with Quantum Mechanics
Matthew Habgood, Tim James, Alexander Heifetz
Methods in molecular biology (2020), pp. 207-229
Closed Access | Times Cited: 22
Unraveling the unbinding pathways of SARS-CoV-2 Papain-like proteinase known inhibitors by Supervised Molecular Dynamics simulation
Farzin Sohraby, Hassan Aryapour
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251910-e0251910
Open Access | Times Cited: 15
Computational prediction of GPCR oligomerization
Andrea Townsend‐Nicholson, Nojood Altwaijry, Andrew Potterton, et al.
Current Opinion in Structural Biology (2019) Vol. 55, pp. 178-184
Closed Access | Times Cited: 16
Artificial Intelligence in The Management of Neurodegenerative Disorders
Sanchit Dhankhar, Somdutt Mujwar, Nitika Garg, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 931-940
Closed Access | Times Cited: 5
Characterising GPCR–ligand interactions using a fragment molecular orbital-based approach
Alexander Heifetz, Tim James, Michelle Southey, et al.
Current Opinion in Structural Biology (2019) Vol. 55, pp. 85-92
Open Access | Times Cited: 15
Introduction to Systems Biology
Nitish Rai, Namita Ashish Singh, Vivek Jain, et al.
(2024), pp. 1-25
Closed Access | Times Cited: 1
Discovery and optimizing polycyclic pyridone compounds as anti-HBV agents
Fenju Wei, Dongwei Kang, Srinivasulu Cherukupalli, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 9, pp. 715-721
Closed Access | Times Cited: 10
Quantitative structure–toxicity relationships in translational toxicology
Svetoslav Slavov, Richard D. Beger
Current Opinion in Toxicology (2020) Vol. 23-24, pp. 46-49
Closed Access | Times Cited: 7
Toward Pharma 4.0 in Drug Discovery
Reza Ebrahimi Hariry, Reza Vatankhah Barenji, Aydin Azizi
Industry 4.0 (2022), pp. 221-238
Closed Access | Times Cited: 4
Case studies on computer-based identification of natural products as lead molecules
Conrad V. Simoben, Fidele Ntie‐Kang, Dina Robaa, et al.
Physical Sciences Reviews (2020) Vol. 5, Iss. 10
Closed Access | Times Cited: 3
DrugBank Online: A How‐to Guide
Christen M. Klinger, Jordan J. Cox, Denise So, et al.
Methods and principles in medicinal chemistry (2023), pp. 67-99
Open Access
Page 1

Scroll to top